Interestingly, while LIF has been demonstrated to exert effects on lipid metabolism in both the brain and in adipocytes via the PI3K/AKT pathway, little research has been done to evaluate how LIF signaling influences cancer metabolism in both glioblastoma and glioma, or in other cancer related pathological states. This evidence concerns the gene AKT1 and cancer.